COLLINS HELEN LOUISE (CHIEF MEDICAL OFFICER) sold 64.3% of their position (45K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.18M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001701247-26-000002
Officer· CHIEF MEDICAL OFFICER
Since Feb 2026
-45K
Net shares
Net seller
$1.18M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
45K acquired · 90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+45K
Price / share
$2.48
Trade value
$111.60K
% of position
180.0%
2/17/2026
25K→70K
Common Stock
Direct
Shares
−45K
Price / share
$26.17
Trade value
$1.18M
% of position
64.3%
2/17/2026
70K→25K
Total
Net shares
+0.00
Net value
-$1.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | M · Option Exercise | +45K | $2.48 | $111.60K | 180.0% | 25K | 70K |
| Common Stock Direct | 2/17/2026 | S · Sale | −45K | $26.17 | $1.18M | 64.3% | 70K | 25K |
| Total | +0.00 | -$1.07M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
45K shares
Shares
−45K
Strike price
2.48
Held after
221.27K
Exercisable
—
2/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock45K shares | 2/17/2026 | M · Option Exercise | −45K | 2.48 | — | 221.27K |